Grants per year
Personal profile
Research Interests
Dr. Ma' clinical and research interests are focused on chronic lymphoid malignancies,including chronic lymphocytic leukemia and non-Hodgkin lymphoma. Dr. Ma directs the clinical and translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translational investigations have included novel biologic agents, mechanisms of drug resistance and immunotherapy. Dr. Ma is the Principal Investigator for a number of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for CLL and lymphoma. She collaborates with investigators at Northwestern University, other US institutions and international institutions in developing novel therapeutic approaches in hematologic malignancies.
Certifications and Licenses
Medical Oncology | |
Hematology | |
Internal Medicine |
Training Experience
2005 | Residency, Resurrection Hospitals |
2008 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
PhD, Northwestern University, Feinberg School of Medicine
… → 2000
MD, Beijing Medical University
… → 1994
Research interests
- Biologic Therapies
- Blood Cancer (leukemia and lymphomas)
- Chronic Lymphocytic Leukemia
- Hematology
- Non-Hodgkin's Lymphoma
- Oncology
Fingerprint
- 6 Similar Profiles
Network
Grants
Research Output
-
Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies
Stasiłojć, G., Felberg, A., Urban, A., Kowalska, D., Ma, S., Blom, A. M., Lundin, J., Österborg, A. & Okrój, M., Jan 2020, In: Journal of Immunological Methods. 476, 112675.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology
Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Lim, M. S., Ma, S. & 10 others, , Feb 1 2020, In: Journal of the National Comprehensive Cancer Network : JNCCN. 18, 2, p. 185-217 33 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
Noy, A., de Vos, S., Coleman, M., Martin, P., Flowers, C. R., Thieblemont, C., Morschhauser, F., Collins, G. P., Ma, S., Peles, S., Smith, S. D., Barrientos, J. C., Chong, E., Wu, S., Cheung, L. W. K., Kwei, K., Hauns, B., Arango-Hisijara, I. & Chen, R., Nov 24 2020, In: Blood Advances. 4, 22, p. 5773-5784 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Mato, A. R., Roeker, L. E., Lamanna, N., Allan, J. N., Leslie, L., Pagel, J. M., Patel, K., Osterborg, A., Wojenski, D., Kamdar, M., Huntington, S. F., Davids, M. S., Brown, J. R., Antic, D., Jacobs, R., Ahn, I. E., Pu, J., Isaac, K. M., Barr, P. M., Ujjani, C. S. & 42 others, , Sep 3 2020, In: Blood. 136, 10, p. 1134-1143 10 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Pseudo-Richter transformation of chronic lymphocytic leukaemia/small lymphocytic lymphoma following ibrutinib interruption: a diagnostic pitfall
Barnea Slonim, L., Ma, S., Behdad, A. & Chen, Q., Oct 1 2020, In: British Journal of Haematology. 191, 1, p. e22-e25Research output: Contribution to journal › Letter › peer-review
Open Access